Mamelle N, Cochet V, Claris O
INSERM, Unit 369, Molecular and Cellular Endocrinology Unit, Research Group: Epidemiology of Growth and Development, Edouard-Herriot Hospital, F-69424 Lyon cedex 03, France.
Biol Neonate. 2001;80(4):277-85. doi: 10.1159/000047157.
Identification of newborn babies with fetal growth restriction remains a problem both from the multi-factorial aspect of fetal growth and from statistical definition. Besides the usual terms: "Small for gestational age" (SGA) and intrauterine growth retardation (IUGR), often used synonymously, the term "fetal growth retardation" was recently introduced in reference to the genetic growth potential of infants. From a sample of 72,000 births, we have designed a statistical model in order to estimate the expected birth weight taking into account gestational age, sex, birth rank, maternal age, height and pregravid weight, we then calculated an individual limit of birth weight under that a newborn must be considered as having a "fetal growth restriction" quoted FwGR. This new approach allowed us to identify 2 groups of newborns with FGR, one classically identified as SGA (noted FwGR(I)) (3.9%), and the other newly identified as FGR (noted FwGR(II)) (1.4%). In contrast, this approach allowed us to identify a group of "constitutionally small" infants according to their constitutional growth potential (1.1%). In other words, among infants usually defined as SGA (5%), 22% appeared in fact to be "constitutionally small" and therefore misclassified. As an initial validation, we observed that the proportion of maternal hypertension during pregnancy was low in the "constitutionally small" infants (close to that of the normal group), and three times higher in the newly identified group FwGR(II) than in the normal group. Following these results, it seems to be meaningful to follow-up this new group of FwGR(II) infants, in terms of catch-up growth and neurodevelopmental outcome.
从胎儿生长的多因素方面以及统计学定义来看,识别患有胎儿生长受限的新生儿仍然是个问题。除了常用术语“小于胎龄儿”(SGA)和宫内生长迟缓(IUGR)(这两个术语常被视为同义词)外,“胎儿生长迟缓”一词最近被引入,用于指代婴儿的遗传生长潜力。我们从72000例出生样本中设计了一个统计模型,以估计考虑到胎龄、性别、产次、母亲年龄、身高和孕前体重后的预期出生体重,然后计算出一个出生体重的个体限值,低于该限值的新生儿必须被视为患有“胎儿生长受限”(记为FwGR)。这种新方法使我们能够识别出两组患有FGR的新生儿,一组是传统上被认定为SGA的(记为FwGR(I))(3.9%),另一组是新识别出的FGR(记为FwGR(II))(1.4%)。相比之下,这种方法使我们能够根据其体质生长潜力识别出一组“体质小”的婴儿(1.1%)。换句话说,在通常被定义为SGA的婴儿(5%)中,实际上有22%似乎是“体质小”的,因此被错误分类。作为初步验证,我们观察到“体质小”婴儿孕期母亲高血压的比例较低(接近正常组),而新识别出的FwGR(II)组比正常组高出三倍。基于这些结果,对这组新的FwGR(II)婴儿进行追赶生长和神经发育结局方面的随访似乎是有意义的。